| Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers AM Evens, A Danilov, D Jagadeesh, A Sperling, SH Kim, R Vaca, C Wei, ... Blood, The Journal of the American Society of Hematology 137 (3), 374-386, 2021 | 89 | 2021 |
| Burkitt lymphoma international prognostic index AJ Olszewski, LH Jakobsen, GP Collins, K Cwynarski, V Bachanova, ... Journal of clinical oncology 39 (10), 1129-1138, 2021 | 59 | 2021 |
| HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysis JP Alderuccio, AJ Olszewski, AM Evens, GP Collins, AV Danilov, M Bower, ... Blood advances 5 (14), 2852-2862, 2021 | 33 | 2021 |
| Outcomes of Burkitt lymphoma with central nervous system involvement: evidence from a large multicenter cohort study AS Zayac, AM Evens, A Danilov, SD Smith, D Jagadeesh, LA Leslie, ... Haematologica 106 (7), 1932, 2021 | 28 | 2021 |
| An international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lymphoma JP Alderuccio, L Arcaini, MP Watkins, AW Beaven, G Shouse, N Epperla, ... Blood advances 6 (7), 2035-2044, 2022 | 18 | 2022 |
| Outcomes of patients with newly-diagnosed Burkitt lymphoma (BL) and central nervous system (CNS) involvement treated in the modern era: A multi-institutional real-world analysis A Zayac, AM Evens, A Stadnik, SD Smith, D Jagadeesh, LA Leslie, C Wei, ... Blood 134, 402, 2019 | 14 | 2019 |
| Older patients with primary central nervous system lymphoma: Survival and prognostication across 20 US cancer centers KA David, S Sundaram, SH Kim, R Vaca, Y Lin, S Singer, MK Malecek, ... American journal of hematology 98 (6), 900-912, 2023 | 9 | 2023 |
| The evaluation and treatment (Tx) of Burkitt lymphoma (BL) in the modern era: real world (RW) outcomes and prognostication across 26 US Cancer Centers (CC) AM Evens, A Danilov, D Jagadeesh, A Sperling, SH Kim, R Vaca, C Wei, ... Blood 134, 397, 2019 | 5 | 2019 |
| Predictive factors and outcomes for ibrutinib in relapsed/refractory marginal zone lymphoma: a multicenter cohort study N Epperla, Q Zhao, SM Chowdhury, L Shea, TK Moyo, N Reddy, J Sheets, ... Journal of Hematology & Oncology 15 (1), 96, 2022 | 4 | 2022 |
| EBV-positive PCNSL in older patients: incidence, characteristics, tumor pathology, and outcomes across a large multicenter cohort P Agrawal, KA David, Z Chen, S Sundaram, SH Kim, R Vaca, Y Lin, ... Leukemia & lymphoma 64 (5), 1026-1034, 2023 | 2 | 2023 |
| Prognostication, survival and treatment-related outcomes in HIV-associated Burkitt lymphoma (HIV-BL): a US and UK collaborative analysis JP Alderuccio, AJ Olszewski, AM Evens, GP Collins, A Danilov, M Bower, ... Blood 136, 49-50, 2020 | 2 | 2020 |
| Real world outcomes of sars-Cov-2 thrombosis rates across three university health systems in the Chicago Metropolitan area S Berg, SH Kim, S Patel, P Rajakumar, EJ Elliott, C Schwartz, J Coggan, ... Blood 136, 58-59, 2020 | 2 | 2020 |
| Outcomes of COVID-19 Infection in Patients with Hematologic Malignancies E Behrens, A Timmermann, A Yerkan, DA Katz, A Paner, MC Larson, ... Blood 136, 20-21, 2020 | 1 | 2020 |
| Real world (RW) outcomes and prognostication of older patients with primary central nervous system lymphoma (PCNSL) in the contemporary era KA David, S Sundaram, SH Kim, R Vaca, Y Lin, S Singer, MK Malecek, ... Blood 136, 24-26, 2020 | 1 | 2020 |
| Outcomes in primary gastrointestinal (GI) follicular lymphoma (FL): results from a multicenter analysis F St‐Pierre, T Alrifai, K Alhamad, B McCall, K Annunzio, X Mi, PG Doukas, ... Hematological Oncology 41, 380-381, 2023 | | 2023 |
| Iatrogenic Immunodeficiency Associated Lymphoproliferative Disorder in a Patient With Inflammatory Bowel Disease BD German, J Akin, SH Kim, C Murphy, P Venugopal, N Lopez-Hisijos, ... Journal of Medical Cases 13 (10), 521, 2022 | | 2022 |
| COVID‐19 thromboembolism incidence, risk factors, and anticoagulation practices from a Chicago metropolitan US population S Berg, SH Kim, A Wozniak, O Odetola, S Arain, A Aleem, J Coggan, ... American Journal of Hematology 97 (6), E217-E220, 2022 | | 2022 |
| The Impact of Non-Clinical Factors in Clinical Trial Enrollments of Patients with Hematologic Malignancies JM Shammo, A Timmermann, DA Katz, A Paner, SH Kim, ML Larson, ... Blood 138, 1914, 2021 | | 2021 |
| EBV-Positive Primary CNS Lymphomas in Older Patients: Incidence, Characteristics, Tumor Pathology, and Outcomes across a Large Multicenter Cohort P Agrawal, KA David, Z Chen, S Sundaram, SH Kim, R Vaca, Y Lin, ... Blood 136, 4-6, 2020 | | 2020 |
